LC–MS/MS Determination of Prednisone, A Drug in Phase 4 of Multiple Sclerosis Therapy along with Teriflunomide and Pioglitazone in Rat Plasma
Combination therapy or polytherapy is that uses more than one medication to treat a single disease and associated diseases. Pharmaceutical combination therapy may be achieved by prescribing separate drugs, or, where available, dosage forms that contain more than one active ingredient. A ran...
Main Authors: | Raja K Rajeswari, A Suneetha |
---|---|
Format: | Article |
Language: | English |
Published: |
Krupanidhi College of Pharmacy
2021-12-01
|
Series: | Journal of Pharmaceutical Research |
Online Access: | https://jopcr.com/articles/lcmsms-determination-of-prednisone-a-drug-in-phase-4-of-multiple-sclerosis-therapy-along-with-teriflunomide-and-pioglitazone-in-rat-plasma |
Similar Items
-
Simultaneous determination of pioglitazone and candesartan in human plasma by LC-MS/MS and its application to a human pharmacokinetic study
by: Vijaya Kumari Karra, et al.
Published: (2012-06-01) -
Bioanalytical method development and validation for quantification of amivantamab in rat plasma by LC-MS/MS
by: Pridhvi Krishna Gaddey, et al.
Published: (2024-04-01) -
Real-life outcomes of teriflunomide treatment in patients with relapsing multiple sclerosis: TAURUS-MS observational study
by: Boris A. Kallmann, et al.
Published: (2019-03-01) -
Teriflunomide in patients with multiple sclerosis
by: N. Y. Lasch, et al.
Published: (2015-12-01) -
LC-MS-MS development and validation for simultaneous quantitation of metformin, glimepiride and pioglitazone in human plasma and its application to a bioequivalence study
by: Sengupta, Pinaki, et al.
Published: (2009)